Abstract
dc:description.abstractCutaneous squamous cell carcinoma (cSCC) is the most common form of human cancer with metastatic potential. Despite T cells accumulating around cSCCs, these tumours continue to grow and persist. To investigate reasons for the failure of T cells to mount a protective response in cSCC, tumoral T cells were characterised to determine factors responsible for cSCC T cell dysfunction. This thesis focused primarily on regulatory T cells (Tregs, which are considered immunosuppressive) and CD8<sup>+</sup> T cells (thought to be responsible for destroying cancer cells) within the population of T cells surrounding cSCCs.<br/><br/>Human primary cSCCs contained increased FOXP3<sup>+</sup> Treg and CD8<sup>+</sup> T cell frequencies compared with corresponding peripheral blood and normal skin. Most tumoral T cells expressed the skin addressin CLA and E-selectin was detected in the majority of peritumoral blood vessels. Functional studies showed that tumoral Tregs suppressed tumoral effector CD4<sup>+</sup> and CD8<sup>+</sup>T cell proliferation and effector T cell interferon-γ secretion in vitro. OX40 was expressed by higher proportions of tumoral Tregs than other T cells (including CD4<sup>+</sup>FOXP3<sup>-</sup> and CD8<sup>+</sup> T cells) and increased OX40<sup>+</sup> lymphocyte frequencies were observed in primary cSCCs which metastasised compared with primary cSCCs which had not metastasised. Furthermore, in vitro OX40 activation of Treg/CD4<sup>+</sup> effector T cell co-cultures enhanced tumoral CD4<sup>+</sup> T cell proliferation, thus overcoming Treg suppression.<br/><br/>Functional data demonstrated that CD8<sup>+</sup> T cells from cSCC were less able to proliferate and produce granzyme B and perforin in vitro than CD8<sup>+</sup> T cells from peripheral blood. In addition, IL-2 was produced by fewer T cells in cSCC than in normal skin. The inhibitory receptor PD-1 was expressed by higher proportions of T cells in cSCC than peripheral blood and PD-1 inhibition augmented in vitro tumoral CD8<sup>+</sup> T cell proliferation.<br/><br/>The results in this thesis highlight that dysfunctional T cell responses are present in cSCC, potentially contributing to ineffective anti-tumour immunity and permitting the development and growth of cSCC. Furthermore, the data in this thesis show that T cells from cSCC can be used for functional assessment of T cell costimulatory/inhibitory antibodies, suggesting this system might be useful as a preclinical tool for investigation of anti-tumour immunotherapies.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D.
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Southampton
- Year dc:date.issued
- 2016
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Lai, Chester
- Advisors dc:contributor.advisor
-
- Healy, Eugene
- Al-Shamkhani, Aymen
- ORCID person:identifier.orcid
Rights
- Language dc:language
- English, eng